Contraception
📧 Sign up to get email alerts when something new happens for Contraception.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-25Clinical Trial Results: A Study to Assess the Safety of a New Inserter Device for Paragard® (Intrauterine Copper Contraceptive) [Phase 4]
Phase 4 trial assessing safety of a new inserter device for Paragard intrauterine copper contraceptive; results completed and posted.
-
FDA approval · 2026-07-28FDA Approved: GWYN LO — Original Application (Viatris Specialty LLC)
FDA approval of GWYN LO, a combined oral contraceptive containing norelgestromin and ethinyl estradiol, from Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2026-07-24Clinical Trial Results: A 3-way Crossover Clinical Investigation to Assess the Performance of Two Different Sized Polyurethane Condoms Versus a Latex Condom in Healthy Monogamous Couples. [NA]
A completed clinical trial comparing two sizes of polyurethane condoms to a latex condom in healthy couples; results posted.
-
CLINICAL_TRIALS research · 2026-06-05Clinical Trial Results: Postpartum Integration of Vaccines and Contraception Trial [NA]
A completed clinical trial evaluating postpartum integration of vaccines and contraception, with results posted.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Arterial Vascular Effects of Estetrol-drospirenone Combined Oral Contraceptive Pill [Phase 3]
Phase 3 trial update evaluating arterial vascular effects of estetrol-drospirenone combined oral contraceptive pill; not yet recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: European Active Surveillance Study of LCS12
The European Active Surveillance Study of LCS12 is currently active but not recruiting, investigating contraception.
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: A Dose-finding Study to Evaluate the Effect of a Contraceptive Vaginal Ring, Releasing Nestorone® and Estradiol, on Cycle Control, Ovulation Inhibition, and Pharmacokinetics in Normal Cycling Women [Phase 2]
Phase 2 dose-finding study evaluating a vaginal ring that releases Nestorone (segesterone acetate) and estradiol for cycle control, ovulatio…
-
FDA approval · 2025-06-20FDA Approved: ETYQA — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for ETYQA (estradiol and norethindrone acetate) from Aurobindo Pharma Limited. This action perta…
-
FDA approval · 2025-06-18FDA Approved: TRI-LEGEST FE 28 DAY — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for TRI-LEGEST FE 28 DAY, a combined oral contraceptive containing norethindrone acetate and ethinyl…
-
FDA approval · 2025-06-17FDA Approved: HAILEY FE 1/20 — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for HAILEY FE 1/20, a combination hormonal contraceptive containing norethindrone acetate, ethinyl e…
-
FDA approval · 2025-06-16FDA Approved: MICROGESTIN 24 FE — Supplemental Application (Mayne Pharma Inc.)
FDA approved a supplemental application for MICROGESTIN 24 FE, a combined oral contraceptive containing norethindrone acetate/ethinyl estrad…
-
FDA approval · 2025-05-22FDA Approved: LUTERA — Supplemental Application (Mayne Pharma Inc.)
FDA approved a supplemental application for LUTERA (levonorgestrel and ethinyl estradiol) submitted by Mayne Pharma Inc.
-
FDA approval · 2025-02-24FDA Approved: MIUDELLA — Original Application (Sebela Women's Health Inc.)
FDA approved MIUDELLA, a copper intrauterine device, under Sebela Women's Health Inc.'s original application. It provides contraception by r…
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: Dose-finding Study of MR-130A-01 Contraceptive Transdermal Patch [Phase 2]
The document summarizes completed Phase 2 dose-finding results for MR-130A-01 Contraceptive Transdermal Patch sponsored by Mylan.
-
FDA approval · 2024-06-13FDA Approved: GEMMILY — Supplemental Application (Xiromed, LLC)
FDA approved a supplemental application for GEMMILY, a combination oral contraceptive containing norethindrone acetate, ethinyl estradiol, a…
-
FDA approval · 2024-05-31FDA Approved: NUVARING — Supplemental Application (Advanz Pharma (US) Corp.)
FDA approved a supplemental application for Nuvaring (etonogestrel and ethinyl estradiol) by Advanz Pharma (US) Corp.
-
FDA approval · 2024-05-06FDA Approved: KAITLIB FE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for KAITLIB FE (norethindrone and ethinyl estradiol) from Lupin Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Progestin-Only Pill Use and Breastfeeding Study [Phase 4]
Phase 4 trial update on progestin-only pill use during breastfeeding; results completed and posted in 2024.
-
FDA approval · 2024-04-05FDA Approved: LARIN 1.5/30 — Supplemental Application (Northstar Rx LLC)
The FDA approved a supplemental application for LARIN 1.5/30, a generic oral contraceptive containing norethindrone acetate and ethinyl estr…
-
FDA approval · 2024-03-28FDA Approved: AUROVELA FE 1/20 — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for AUROVELA FE 1/20, a generic combined oral contraceptive containing norethindrone acetate, et…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive Age [Phase 1]
Phase 1 pharmacokinetic study evaluating Medroxyprogesterone Acetate after injection of TV-46046 in healthy women of reproductive age; compl…
-
FDA approval · 2024-02-16FDA Approved: NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for a norethindrone acetate and ethinyl estradiol oral contraceptive product from Glenmark.
-
FDA approval · 2024-02-16FDA Approved: NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL — Supplemental Application (Nivagen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for norethindrone acetate and ethinyl estradiol from Nivagen Pharmaceuticals, a combined oral co…
-
CLINICAL_TRIALS trial_result · 2024-02-12Clinical Trial Update: Nexplanon Application Post-Abortion (NAPA) [NA]
Completed clinical trial investigating Nexplanon (etonogestrel implant) application after abortion; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-02-12Clinical Trial Update: Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle [Phase 1]
Phase 1 study evaluating suppression of ovulation and pharmacokinetics of medroxyprogesterone acetate after TV-46046 in women with ovulatory…